Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Top Cited Papers
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (2), 287-291
- https://doi.org/10.1161/01.str.0000153015.57892.66
Abstract
Background and Purpose— Systemic thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...Keywords
This publication has 23 references indexed in Scilit:
- Teleneurology to Improve Stroke Care in Rural AreasStroke, 2003
- Telemedicine in Emergency Evaluation of Acute StrokeStroke, 2003
- Acute Treatment of Ischaemic StrokeCerebrovascular Diseases, 2003
- Remote Evaluation of Acute Ischemic StrokeStroke, 2003
- Teleradiology Assessment of Computerized Tomographs Online Reliability Study (TRACTORS) for Acute Stroke EvaluationTelemedicine and e-Health, 2003
- Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital MortalityStroke, 2003
- Telemedicine for Acute StrokeStroke, 2003
- Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural ResidentsStroke, 2003
- Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic StrokePharmacoEconomics, 2001
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995